241 related articles for article (PubMed ID: 22969412)
1. Stat5 signaling specifies basal versus stress erythropoietic responses through distinct binary and graded dynamic modalities.
Porpiglia E; Hidalgo D; Koulnis M; Tzafriri AR; Socolovsky M
PLoS Biol; 2012 Aug; 10(8):e1001383. PubMed ID: 22969412
[TBL] [Abstract][Full Text] [Related]
2. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis.
Menon MP; Karur V; Bogacheva O; Bogachev O; Cuetara B; Wojchowski DM
J Clin Invest; 2006 Mar; 116(3):683-94. PubMed ID: 16511603
[TBL] [Abstract][Full Text] [Related]
3. EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis.
Hidalgo D; Bejder J; Pop R; Gellatly K; Hwang Y; Maxwell Scalf S; Eastman AE; Chen JJ; Zhu LJ; Heuberger JAAC; Guo S; Koury MJ; Nordsborg NB; Socolovsky M
Nat Commun; 2021 Dec; 12(1):7334. PubMed ID: 34921133
[TBL] [Abstract][Full Text] [Related]
4. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
5. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
[TBL] [Abstract][Full Text] [Related]
6. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts.
Socolovsky M; Nam H; Fleming MD; Haase VH; Brugnara C; Lodish HF
Blood; 2001 Dec; 98(12):3261-73. PubMed ID: 11719363
[TBL] [Abstract][Full Text] [Related]
7. Iron-loaded transferrin potentiates erythropoietin effects on erythroblast proliferation and survival: a novel role through transferrin receptors.
Fouquet G; Thongsa-Ad U; Lefevre C; Rousseau A; Tanhuad N; Khongkla E; Saengsawang W; Anurathapan U; Hongeng S; Maciel TT; Hermine O; Bhukhai K
Exp Hematol; 2021 Jul; 99():12-20.e3. PubMed ID: 34077792
[TBL] [Abstract][Full Text] [Related]
8. Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.
Han Y; Gao C; Liu Y; Zhang H; Wang S; Zhao H; Bao W; Guo X; Vinchi F; Lobo C; Shi P; Mendelson A; Luchsinger L; Zhong H; Yazdanbakhsh K; An X
Blood; 2024 Mar; 143(11):1018-1031. PubMed ID: 38127913
[TBL] [Abstract][Full Text] [Related]
9. Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.
Singh S; Dev A; Verma R; Pradeep A; Sathyanarayana P; Green JM; Narayanan A; Wojchowski DM
PLoS One; 2012; 7(7):e38530. PubMed ID: 22808010
[TBL] [Abstract][Full Text] [Related]
10. Core erythropoietin receptor signals for late erythroblast development.
Menon MP; Fang J; Wojchowski DM
Blood; 2006 Apr; 107(7):2662-72. PubMed ID: 16332976
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway.
Yoon D; Watowich SS
Exp Hematol; 2003 Dec; 31(12):1310-6. PubMed ID: 14662339
[TBL] [Abstract][Full Text] [Related]
12. Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR.
Dolznig H; Grebien F; Deiner EM; Stangl K; Kolbus A; Habermann B; Kerenyi MA; Kieslinger M; Moriggl R; Beug H; Müllner EW
Oncogene; 2006 May; 25(20):2890-900. PubMed ID: 16407844
[TBL] [Abstract][Full Text] [Related]
13. Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis.
Chang HC; Huang DY; Wu MS; Chu CL; Tzeng SJ; Lin WW
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):687-696. PubMed ID: 28131718
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin receptors that signal through Stat5 or Stat3 support fetal liver and adult erythropoiesis: lack of specificity of stat signals during red blood cell development.
Watowich SS; Mikami A; Busche RA; Xie X; Pharr PN; Longmore GD
J Interferon Cytokine Res; 2000 Dec; 20(12):1065-70. PubMed ID: 11152572
[TBL] [Abstract][Full Text] [Related]
15. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction.
Okonko DO; Marley SB; Anker SD; Poole-Wilson PA; Gordon MY
Int J Cardiol; 2013 Apr; 164(3):359-64. PubMed ID: 21821297
[TBL] [Abstract][Full Text] [Related]
17. Activation of STAT5 during EPO-directed suppression of apoptosis.
Bittorf T; Seiler J; Lüdtke B; Büchse T; Jaster R; Brock J
Cell Signal; 2000 Jan; 12(1):23-30. PubMed ID: 10676844
[TBL] [Abstract][Full Text] [Related]
18. Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models.
Wang J; Hayashi Y; Yokota A; Xu Z; Zhang Y; Huang R; Yan X; Liu H; Ma L; Azam M; Bridges JP; Cancelas JA; Kalfa TA; An X; Xiao Z; Huang G
Haematologica; 2018 Jan; 103(1):40-50. PubMed ID: 29051279
[TBL] [Abstract][Full Text] [Related]
19. Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.
Grebien F; Kerenyi MA; Kovacic B; Kolbe T; Becker V; Dolznig H; Pfeffer K; Klingmüller U; Müller M; Beug H; Müllner EW; Moriggl R
Blood; 2008 May; 111(9):4511-22. PubMed ID: 18239084
[TBL] [Abstract][Full Text] [Related]
20. EPO receptor circuits for primary erythroblast survival.
Sathyanarayana P; Dev A; Fang J; Houde E; Bogacheva O; Bogachev O; Menon M; Browne S; Pradeep A; Emerson C; Wojchowski DM
Blood; 2008 Jun; 111(11):5390-9. PubMed ID: 18349318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
